Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myomo (MYO) EBIT (2016 - 2025)

Historic EBIT for Myomo (MYO) over the last 10 years, with Q3 2025 value amounting to -$3.5 million.

  • Myomo's EBIT fell 26734.41% to -$3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.9 million, marking a year-over-year decrease of 4144.16%. This contributed to the annual value of -$6.2 million for FY2024, which is 2459.87% up from last year.
  • According to the latest figures from Q3 2025, Myomo's EBIT is -$3.5 million, which was down 26734.41% from -$4.6 million recorded in Q2 2025.
  • Myomo's EBIT's 5-year high stood at -$245314.0 during Q4 2024, with a 5-year trough of -$4.6 million in Q2 2025.
  • In the last 5 years, Myomo's EBIT had a median value of -$2.7 million in 2023 and averaged -$2.5 million.
  • As far as peak fluctuations go, Myomo's EBIT skyrocketed by 8991.8% in 2024, and later tumbled by 31166.43% in 2025.
  • Myomo's EBIT (Quarter) stood at -$2.7 million in 2021, then increased by 17.61% to -$2.2 million in 2022, then fell by 9.14% to -$2.4 million in 2023, then soared by 89.92% to -$245314.0 in 2024, then tumbled by 1333.88% to -$3.5 million in 2025.
  • Its EBIT was -$3.5 million in Q3 2025, compared to -$4.6 million in Q2 2025 and -$3.5 million in Q1 2025.